Soligenix, Inc. (SNGX) — 10-Q Filings

10-Q Filings (6)

• Soligenix Losses Widen Amid R&D Surge, Secures $7.5M in Public Offering — Nov 7, 2025 Risk: high
  SOLIGENIX, INC. (SNGX) reported a net loss of $8,184,191 for the nine months ended September 30, 2025, a significant increase from the $5,279,210 net loss in th
• Soligenix's Losses Widen Amid Soaring R&D Costs, Cash Dwindles — Aug 14, 2025 Risk: high
  SOLIGENIX, INC. (SNGX) reported a significant increase in net loss for the six months ended June 30, 2025, reaching $5,653,244, compared to a net loss of $3,559
• Soligenix Q1 Revenue Surges to $1.06M — May 9, 2025 Risk: medium
  Soligenix, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported revenues of $1.06 million for the first quarter of 2025, a significant
• Soligenix Reports Q3 2024 Results: Net Loss Narrows — Nov 8, 2024 Risk: high
  Soligenix, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported a net loss of $2.56 million for the nine months ended September 30
• Soligenix, Inc. Files 10-Q for Q2 2024 — Aug 9, 2024 Risk: medium
  Soligenix, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business activities.
• SOLIGENIX, INC. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: medium
  SOLIGENIX, INC. (SNGX) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. The company filed a 10-Q for the period ending March 31, 2024. The filing i

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX